Item

Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

Author
Edmonds, Sterling, MacGregor, Andrea, Doll, Agnieszka, Vural, Ipek Eren, Graham, Janice, Fierlbeck, Katherine, Lexchin, Joel, Doshi, Peter, Herder, Matthew
Advisor
Date
2020-11-19
Embargo until
Language
Book title
Journal
Journal of Law and the Biosciences
Publisher
Oxford University Press
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Dr. Peter Doshi
Show all metadata
Other Titles
See at
https://doi.org/10.1093/jlb/lsaa083
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
Series/Report No.
Sponsors
Rights/Terms
Citation
Keyword
COVID-19
 pandemic
 pharmaceutical regulation
 transparency
 vaccines and drugs
Identifier to cite or link to this item
http://hdl.handle.net/10713/14655
Scopus Identifier
Embedded videos